CHAMPIONS ONCOLOGY, INC. (CSBR) Revenue 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$59.4MFY2026 · since FY2018: $20.2M → $59.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $59.4M | +4.4% |
| FY2025 | $56.9M | +13.5% |
| FY2024 | $50.2M | -6.9% |
| FY2023 | $53.9M | +9.7% |
| FY2022 | $49.1M | +19.7% |
| FY2021 | $41.0M | +27.8% |
| FY2020 | $32.1M | +18.7% |
| FY2019 | $27.1M | +33.7% |
| FY2018 | $20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice